Evidence map›Paper›PMID 34730266›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Truly-Biocompatible Gold Catalysis Enables Vivo-Orthogonal Intra-CNS Release of Anxiolytics.

M Carmen Ortega-Liebana, Nicola J Porter, Catherine Adam, Teresa Valero, Lloyd Hamilton, Dirk Sieger, Catherina G Becker, Asier Unciti-Broceta

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Nano letters · 2023
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

M Carmen Ortega-LiebanaCancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.ORCID 0000-0001-5835-1223
Nicola J PorterCentre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB, UK.ORCID 0000-0003-1582-9383
Catherine AdamCancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Teresa ValeroCancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.ORCID 0000-0002-3625-311X
Lloyd HamiltonCentre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB, UK.ORCID 0000-0002-2314-2410
Dirk SiegerCentre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB, UK.ORCID 0000-0001-6881-5183
Catherina G BeckerCentre for Discovery Brain Sciences, The Chancellor's Building, University of Edinburgh, Edinburgh, EH16 4SB, UK.ORCID 0000-0002-9501-6165
Asier Unciti-BrocetaCancer Research UK Edinburgh Centre, Institute of Genetics & Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.ORCID 0000-0003-1029-2855
Edinburgh Cancer Research · GBUniversity of Edinburgh · GBTechnische Universität Dresden · DE

Funding

Cancer Research UK 17494Cancer Research UK Career Establishment AwardCancer Research UK CRUK PhD fellowship
6 · The paper itself

Abstract

Being recognized as the best-tolerated of all metals, the catalytic potential of gold (Au) has thus far been hindered by the ubiquitous presence of thiols in organisms. Herein we report the development of a truly-catalytic Au-polymer composite by assembling ultrasmall Au-nanoparticles at the protein-repelling outer layer of a co-polymer scaffold via electrostatic loading. Illustrating the in vivo-compatibility of the novel catalysts, we show their capacity to uncage the anxiolytic agent fluoxetine at the central nervous system (CNS) of developing zebrafish, influencing their swim pattern. This bioorthogonal strategy has enabled -for the first time- modification of cognitive activity by releasing a neuroactive agent directly in the brain of an animal.

Indexed as

AnimalsAnti-Anxiety AgentsBiocompatible MaterialsCatalysisCentral Nervous SystemGoldMolecular StructureParticle SizeZebrafishAnti-Anxiety AgentsBiocompatible MaterialsGoldbehavioral activitybioorthogonalcatalysisgoldprodrug

Identifiers

PMID34730266
PMCPMC9299494
OpenAlexW3210208716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.